SlideShare a Scribd company logo
1 of 47
Download to read offline
Dr. Mustafa Sayed 
Prof . Of Nuclear Medicine 
Asyut University , Egypt.
 Myocardial perfusion scintigraphy descrip sequential 
physiological events: 
-First, the materials(radiopharmacuticals) must be 
delivered to the myocardium. 
-Second, a viable metabolically active myocardial cell 
must be present to extract this material. 
-Finally, a significant amount of the material must 
remain within the cell to allow for imaging. 
 The scintigraphic images are a map of regional 
myocardial perfusion. 
 If a patient has reduced regional perfusion as a result 
of hemodynamically significant (CAD) or a loss of 
cell viability as a result of myocardial infarction, a 
perfusion defect or cold region is seen on the images. 
 All diagnostic patterns in the many diverse 
applications follow from these observations
 The radiopharmaceutical is a combination of 
radioactive material used alone or mixed with 
inert kits. These materials have selective 
affinity to target cell components. 
 These radiopharmaceuticals emit gamma rays 
which are collected by special instrumentations 
called gamma camera which has different 
types. 
 These types include multi view planar imaging 
which was followed by single-photon emission 
tomography (SPECT), gated SPECT, 
SPECT/CT, then positron emission 
tomography (PET),and PET/CT.
 Such radipharmaceuticals are injected under stress 
as well as resting conditions, and images are 
obtained to define the regional distribution of 
radioactivity within the myocardium. 
 
 First used for myocardial scintigraphy in the mid- 
1970s, it was the only perfusion agent available 
until the 1990s, when Tc-99m–labeled radiotracers 
were introduced. Tl-201 is less commonly used today 
because of its poorer image quality. 
 At some imaging clinics it is used for the rest 
study in dual-isotope studies or for viability 
studies
 Mechanism of Localization and Pharmacokinetics: 
After intravenous injection, Tl-201 blood clearance is 
rapid. It is transported across the myocardial cell 
membrane via the Na+/K+ ATPase pump. More 
than 85% is extracted by the myocardial cell on 
first pass through the coronary capillary 
circulation . Peak myocardial uptake occurs by 10 
minutes. Approximately 3% of the administered 
dose localizes in the myocardium. 
Extraction is proportional to relative regional 
perfusion over a range of flow rates. At high flow 
rates, extraction efficiency decreases; at low rates, 
it increases. 
It can only be extracted by viable myocardium, but 
not in regions of infarction or scar.
Tc-99m is the radiotracer which emits gamma rays 
and can be labelled with different materials. 
= Technetium-99m MIBI: approved by the (FDA) 
for clinical use in 1990. Generic Tc-99m sestamibi 
became available late (chemical name: hexakis 2- 
೦Methoxy Iso Butyl Isonitrile). 
Mechanism of Localization and Uptake: Because it is lipid 
soluble, Tc-99m mibi diffuses from the blood into 
the myocardial cell. It is retained intracellular in 
the mitochondria because of its negative 
transmembrane potential. First-pass extraction 
fraction is 60% . Extraction is proportional to 
coronary blood flow.
= Technetium-99m Tetrofosmin:Tc-99m 
tetrofosmin (Myoview) was approved by the 
FDA in 1996. An advantage over Tc-99m mibi 
is its more rapid liver clearance. 
 Mechanism of Localization and Uptake: Similar to 
mibi, Tc-99m tetrofosmin is a lipophilic cation 
that localizes inside mitochondria in the 
myocardial cell and remains fixed at that site. 
First-pass extraction is slightly less than that of 
mibi (50% vs. 60%). Extraction is proportional 
to blood flow, but underestimated at high flow 
rates. It is widely used nowadays.
 Single Photon Emission Computed 
Tomography: 
SPECT is the standard method for myocardial 
perfusion scintigraphy. The cross-sectional 
images have high contrast resolution and are 
displayed three-dimension along the short and 
long axis of the heart providing good 
delineation of the various regional myocardial 
perfusion beds supplied by their individual 
coronary arteries.
The diagram shows a photon reaching the NaI crystal through the collimator and 
undergoing photoelectric absorption. The photomultiplier tubes (PMTs) are 
optically coupled to the NaI crystal. The electrical outputs from the respective 
PMTs are further processed through positioning circuitry to calculate (x, y) 
coordinates and through addition circuitry to calculate the deposited energy of the 
pulse. The energy signal passes through the pulse height analyzer. If the event is 
accepted, it is recorded spatially in the location determined by the (x,y) positioning 
pulses to form the image.
Cardiac SPECT software: reconstructs cross-sectional 
cardiac images along the short and 
long axes of the heart , that is, transaxial (short 
axis), coronal (horizontal long axis), and 
sagittal (vertical long axis) . 
The SPECT cross-sectional images descrip the 
regional perfusion of the myocardium as it 
relates to the coronary artery supplying blood 
to that region and permits visual estimation of 
the degree and extent of the perfusion 
abnormality
 Cardiac stress testing with ECG monitoring has 
long been used to diagnose ischemic coronary 
artery diseases. 
 Cardiac stress can be physical by graded 
treadmill or pharmacological with specific 
drugs. 
 The SPECT imaging provides valuable 
information on the extent and severity of 
coronary artery disease which is useful for risk 
assessment, prognosis, and patient 
management.
 The patients must be fasting for 4 to 6 hours before the 
test to prevent stress-induced gastric distress and 
minimize splanchnic blood distribution. 
 Cardiac medications may be held depending on the 
indication for the stress test—that is, whether for 
diagnosis or to determine the effectiveness of therapy 
and type of stress. 
Beta blockers may prevent achievement of maximum 
heart rate. 
Nitrates and calcium channel blockers may mask or 
prevent cardiac ischemia,so limiting the test’s 
diagnostic value. 
Assessment of drug therapy effectiveness requires the 
patient to remain on medication. 
Thyophylline and caffeine also held before 
pharmacological test.
Withdrawal Drugs interval 
48 hours 
24 hours (also with pharma.) 
24 hours (also with pharma.) 
24 hours 
24 hours 
In EXERCIS 
beta blockers 
Calcium channel blockers 
Nitrates 
In PHARMACOLOGICAL 
Thyophylline derivatives 
Caffeine
 In addition to a standard 12-lead baseline ECG, an intravenous line is 
kept open. The patient is continuously monitored during the study. 
 Graded treadmill exercise is performed according to a standardized 
Bruce protocol. 
 When the patient has achieved maximal exercise or peak patient 
tolerance the radio-pharmaceutical is injected. 
 The adequacy of exercise is judged by the degree of cardiac work. 
Patients achieving more than 85% of the age-predicted maximum 
heart rate (220 − age = maximum predicted heart rate) are considered 
to have achieved adequate exercise, stress metabolic equivalents 
(METS) also can be used to judge the adequacy of exercise. Failure to 
achieve adequate exercise is the most common reason for a false negative 
stress test result. 
 Exercise is continued for another 1 minute after injection of 
radiotracer to ensure adequate uptake. 
 Early discontinuation of exercise may result in tracer distribution 
reflecting perfusion at sub maximal exercise levels.
1- Coronary Vasodilating Drugs: Dipyridamole, 
Adenosine, and Regadenoson. 
 Dipyridamole (Persantine) and adenosine 
(Adenoscan) are coronary vasodilating drugs that have 
long been used for stress myocardial perfusion 
imaging. Regadenoson (Lexiscan) was approved by the 
FDA in 2009 but dipyridamole is the widely used . 
 The vasodilators increase coronary blood flow in 
normal vessels 3 to 5 times. Because coronary arteries 
with significant stenoses cannot increase blood flow to 
the same degree as normal vessels, vasodilator stress 
results in vascular regions of relative hypoperfusion on 
myocardial perfusion scintigraphy similar to that seen 
with exercise-induced ischemia.
 Dipyridamole injection protocol: 
- Dose 0.56 mg / Kg diluted in 50 ml normal saline 
and given as infusion for 4 minutes. 
- The radiopharmaceutical should be injected after 
2-4 minutes after completion of infusion. 
- It is contraindicated in bronchial asthma and 
preferred in LBBB cases. 
- Heart rate, blood pressure and ECG should be 
measured and recorded at baseline and every 2 
minutes during the infusion until stress-induced 
haemodynamic changes are improving and the 
patient regains baseline status.
 2- Inotropic Drugs: Dobutamine is a synthetic 
catecholamine that acts on alpha- and beta-adrenergic 
receptors producing inotropic and chronotropic effects 
that increase cardiac work. 
 In normal coronary arteries, increased blood flow is the 
result. In the face of significant stenosis, regional flow 
does not increase, producing scintigraphic patterns 
similar to that seen with ischemia . 
 Dobutamine injection protocol: Initial infusion rate is 5 
μg/kg/min over 3 minutes, then increased to 10 
μg/kg/min for another 3 minutes and further 
increased by that amount every 10 minutes until a 
maximum of 40 μg/kg/min is achieved. 
The radiopharmaceutical is injected after the maximal 
tolerable dose reaching the target heart rate and the 
dobutamine infusion is continue for 1 minute.
Stress Rest 
Radiopharmaceutical 25 m Ci 25 m Ci 
dose 
Supine or prone 
45-60 min. 
Supine or prone 
20 – 30 min with 
exercise 
45-60 min with drugs 
Patient position 
Injection - Imaging 
Time
After initial assessment of the presence or absence 
of perfusion defects, a complete evaluation of 
the stress study includes assessment of the 
location, size, severity, and likely vascular 
distribution of the visualized abnormalities. 
A true perfusion defect should be seen on more 
than one cross-sectional slice and in other 
cross-section planes. Certainty increases with 
lesion size and the degree or severity of photon 
deficiency.
1 
0 
4 
2 
4 
4 
1 
2 
2 
3 
4 
4 
100% 
70 
50 
30 
10 
0 
4 normal 100 - 70% 
3 mild 70 - 50% 
2 moderate 50 - 30% 
1 severe 30 - 10% 
0 absent 10 - 0%
Perfusion defects in more than one coronary 
artery distribution area indicate multiple vessel 
disease. Prognosis worsens with increasing 
number and size of perfusion defects . 
Not all significant coronary artery stenoses are 
always seen on stress perfusion scans. 
N.B. Stress-induced ischemia of the most severe 
stenotic lesion limits further exercise, and thus 
other stenoses may not be seen and multiple 
vessel disease may be underestimated.
The normal cardiac response is to dilate mildly 
during stress and return to normal size 
promptly with cessation of exercise. 
Post stress significant ventricular dilation is 
abnormal and suggests multi vessel disease. 
One explanation for this finding is myocardial 
stunning during stress ,another is widespread 
subendocardial ischemia.
The effects of soft tissue attenuation can be seen 
on most cardiac images and are worse with 
large patients. Males typically have decreased 
activity in the inferior wall . 
This is called diaphragmatic attenuation, meaning 
attenuation by subdiaphragmatic organs 
interpositioned between the heart and gamma 
camera. 
The amount of attenuation effect is dependent 
on patient size, shape, and internal anatomy.
Women often have relatively decreased activity in 
the anterior wall, apex, or anterior lateral 
portion of the heart, secondary to breast 
attenuation, depending on the size and 
position of the breasts. 
Women also may have sub diaphragmatic 
attenuation, but breast attenuation is dominant 
and most commonly noted. 
The cinematic rotating raw data should be 
reviewed for the presence of attenuation and 
motion. If the breasts are in different positions 
for the two studies, this could be 
misinterpreted as ischemia
Exercise-induced reversible hypo perfusion of the septum 
can be seen in patients with left bundle branch block 
(LBBB) in the absence of coronary disease. 
Typically, the apex and anterior wall are not involved, as 
would be expected with left anterior descending (LAD) 
coronary artery disease. 
The stress-induced decreased septal blood flow is thought to 
be caused by asynchronous relaxation of the septum, 
which is out of phase with diastolic filling of the 
remainder of the ventricle when coronary perfusion is 
maximal. 
This scan abnormality is less seen with pharmacological 
stress, and thus the latter is indicated in patients with 
LBBB or ventricular pacemakers.
 ECG is acquired at the time of the SPECT 
acquisition for simultaneous assessment of 
perfusion and function of the left ventricle in one 
examination. 
 Evaluation of regional wall motion and systolic 
thickening of the left ventricular walls . 
 Left ventricular end-diastolic volume, end-systolic 
volume, stroke volume and ejection fraction may 
be calculated automatically, although the values 
obtained should be checked against initial 
qualitative assessment
 Decreased sensitivity and specificity in single vessel 
CAD ( 60 – 76% ) 
 Diffuse disease in all three vessels (Balanced 
ischemia) 
 Diffuse disease without segmental stenosis 
(Vulnerable for plaque rupture and coronary events) 
 Early disease identification 
 Artifacts – Non uniform attenuation 
 Relative low efficiency of Gamma camera 
 Longer acquisition protocols
THANK YOU

More Related Content

What's hot

Anatomy and imaging of coronary artery disease with
Anatomy  and imaging of coronary artery disease withAnatomy  and imaging of coronary artery disease with
Anatomy and imaging of coronary artery disease withSarbesh Tiwari
 
Angiography basics and seldinger technique
Angiography basics and seldinger techniqueAngiography basics and seldinger technique
Angiography basics and seldinger techniqueSamuel Hernandez
 
Peripheral angiography
Peripheral angiographyPeripheral angiography
Peripheral angiographyInosRagan
 
Cardiac MRI
Cardiac MRICardiac MRI
Cardiac MRIaravazhi
 
Nuclear Medicine - Cardiac PET/CT
Nuclear Medicine - Cardiac PET/CTNuclear Medicine - Cardiac PET/CT
Nuclear Medicine - Cardiac PET/CT@Saudi_nmc
 
Myocardial viability
Myocardial viability  Myocardial viability
Myocardial viability Prithvi Puwar
 
Role of nuclear medicine
Role of nuclear medicineRole of nuclear medicine
Role of nuclear medicineLokender Yadav
 
Nuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case StudyNuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case Study@Saudi_nmc
 
Cardiac Magnetic Resonance Imaging
Cardiac Magnetic Resonance ImagingCardiac Magnetic Resonance Imaging
Cardiac Magnetic Resonance ImagingRahman Ud Din
 
Ct coronary angiography edited 1st
Ct   coronary  angiography edited 1stCt   coronary  angiography edited 1st
Ct coronary angiography edited 1stYashawant Yadav
 
Ct angio in cardiology
Ct angio in cardiologyCt angio in cardiology
Ct angio in cardiologyAmit Verma
 
Catheters $ guidewires
Catheters $ guidewiresCatheters $ guidewires
Catheters $ guidewiresEmeka Ubah
 
Cardiac MRI basics
Cardiac MRI basicsCardiac MRI basics
Cardiac MRI basicsshaikAsma10
 
Magnetic Resonance Diffusion
Magnetic Resonance DiffusionMagnetic Resonance Diffusion
Magnetic Resonance DiffusionRahman Ud Din
 
CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)SCGH ED CME
 

What's hot (20)

Anatomy and imaging of coronary artery disease with
Anatomy  and imaging of coronary artery disease withAnatomy  and imaging of coronary artery disease with
Anatomy and imaging of coronary artery disease with
 
Angiography basics and seldinger technique
Angiography basics and seldinger techniqueAngiography basics and seldinger technique
Angiography basics and seldinger technique
 
Peripheral angiography
Peripheral angiographyPeripheral angiography
Peripheral angiography
 
Cardiac mri
Cardiac mriCardiac mri
Cardiac mri
 
Cardiac MRI
Cardiac MRICardiac MRI
Cardiac MRI
 
Nuclear Medicine - Cardiac PET/CT
Nuclear Medicine - Cardiac PET/CTNuclear Medicine - Cardiac PET/CT
Nuclear Medicine - Cardiac PET/CT
 
Myocardial viability
Myocardial viability  Myocardial viability
Myocardial viability
 
Cardiac CT
Cardiac CT Cardiac CT
Cardiac CT
 
Role of nuclear medicine
Role of nuclear medicineRole of nuclear medicine
Role of nuclear medicine
 
Nuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case StudyNuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case Study
 
Coronary CT Angiography
Coronary CT Angiography Coronary CT Angiography
Coronary CT Angiography
 
Cardiac MRI
Cardiac MRICardiac MRI
Cardiac MRI
 
Cardiac Magnetic Resonance Imaging
Cardiac Magnetic Resonance ImagingCardiac Magnetic Resonance Imaging
Cardiac Magnetic Resonance Imaging
 
Ct coronary angiography edited 1st
Ct   coronary  angiography edited 1stCt   coronary  angiography edited 1st
Ct coronary angiography edited 1st
 
Ct angio in cardiology
Ct angio in cardiologyCt angio in cardiology
Ct angio in cardiology
 
Catheters $ guidewires
Catheters $ guidewiresCatheters $ guidewires
Catheters $ guidewires
 
Cardiac MRI basics
Cardiac MRI basicsCardiac MRI basics
Cardiac MRI basics
 
Magnetic Resonance Diffusion
Magnetic Resonance DiffusionMagnetic Resonance Diffusion
Magnetic Resonance Diffusion
 
CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)CT Coronary Angiography (CTCA)
CT Coronary Angiography (CTCA)
 
Coronary CT
Coronary CTCoronary CT
Coronary CT
 

Similar to Myocardial Perfusion Scintigraphy Techniques

Nuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeonsNuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeonsSrikanthK120
 
Nuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case StudyNuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case Study@Saudi_nmc
 
Anaesthesia for pheochromacytoma
Anaesthesia for pheochromacytomaAnaesthesia for pheochromacytoma
Anaesthesia for pheochromacytomaVishal Cb
 
Anaesthetic management of pheochromocytoma
Anaesthetic management of pheochromocytomaAnaesthetic management of pheochromocytoma
Anaesthetic management of pheochromocytomaSiti Azila
 
Management of cardiac arrest
Management of cardiac arrestManagement of cardiac arrest
Management of cardiac arrestHimanshu Rathore
 
Nuclear medicine a guide for healthcare professionals and patients
Nuclear medicine a guide for healthcare professionals and patientsNuclear medicine a guide for healthcare professionals and patients
Nuclear medicine a guide for healthcare professionals and patientsDibya Prakash
 
Bio-Markers of Heart Failure (Dr.LIKHIT T)
Bio-Markers of Heart Failure (Dr.LIKHIT T)Bio-Markers of Heart Failure (Dr.LIKHIT T)
Bio-Markers of Heart Failure (Dr.LIKHIT T)Likhit T
 
Fibrinolytic treatment of acute myocardial infarction by tenecteplase
Fibrinolytic treatment of acute myocardial infarction by tenecteplaseFibrinolytic treatment of acute myocardial infarction by tenecteplase
Fibrinolytic treatment of acute myocardial infarction by tenecteplasedesktoppc
 
Shock in Trauma.pptx
Shock in Trauma.pptxShock in Trauma.pptx
Shock in Trauma.pptxprabhatbhati3
 
Stress echo.pptx
Stress echo.pptxStress echo.pptx
Stress echo.pptxgshah205
 
Surgically correctable hypertension
Surgically correctable hypertensionSurgically correctable hypertension
Surgically correctable hypertensionPraveen Ganji
 
A hint about inotropes and vasopressors
A hint about inotropes and vasopressorsA hint about inotropes and vasopressors
A hint about inotropes and vasopressorsAmr Moustafa Kamel
 
Dr,nidhi gupta aiims.
Dr,nidhi gupta aiims.Dr,nidhi gupta aiims.
Dr,nidhi gupta aiims.Vivek Kekare
 

Similar to Myocardial Perfusion Scintigraphy Techniques (20)

Nuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeonsNuclear medicine for cardiothoracic surgeons
Nuclear medicine for cardiothoracic surgeons
 
Nuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case StudyNuclear Medicine - MPI - Case Study
Nuclear Medicine - MPI - Case Study
 
MPS approach.pdf
MPS approach.pdfMPS approach.pdf
MPS approach.pdf
 
Anaesthesia for pheochromacytoma
Anaesthesia for pheochromacytomaAnaesthesia for pheochromacytoma
Anaesthesia for pheochromacytoma
 
Anaesthetic management of pheochromocytoma
Anaesthetic management of pheochromocytomaAnaesthetic management of pheochromocytoma
Anaesthetic management of pheochromocytoma
 
16 cardiac
16 cardiac16 cardiac
16 cardiac
 
cardiac biomarker
cardiac biomarkercardiac biomarker
cardiac biomarker
 
Management of cardiac arrest
Management of cardiac arrestManagement of cardiac arrest
Management of cardiac arrest
 
Nuclear medicine a guide for healthcare professionals and patients
Nuclear medicine a guide for healthcare professionals and patientsNuclear medicine a guide for healthcare professionals and patients
Nuclear medicine a guide for healthcare professionals and patients
 
Bio-Markers of Heart Failure (Dr.LIKHIT T)
Bio-Markers of Heart Failure (Dr.LIKHIT T)Bio-Markers of Heart Failure (Dr.LIKHIT T)
Bio-Markers of Heart Failure (Dr.LIKHIT T)
 
Stress Echocardiography
Stress EchocardiographyStress Echocardiography
Stress Echocardiography
 
Fibrinolytic treatment of acute myocardial infarction by tenecteplase
Fibrinolytic treatment of acute myocardial infarction by tenecteplaseFibrinolytic treatment of acute myocardial infarction by tenecteplase
Fibrinolytic treatment of acute myocardial infarction by tenecteplase
 
Shock in Trauma.pptx
Shock in Trauma.pptxShock in Trauma.pptx
Shock in Trauma.pptx
 
Stress echo.pptx
Stress echo.pptxStress echo.pptx
Stress echo.pptx
 
Surgically correctable hypertension
Surgically correctable hypertensionSurgically correctable hypertension
Surgically correctable hypertension
 
S12968 020-00607-1
S12968 020-00607-1S12968 020-00607-1
S12968 020-00607-1
 
Cardiac scanning
Cardiac scanningCardiac scanning
Cardiac scanning
 
A hint about inotropes and vasopressors
A hint about inotropes and vasopressorsA hint about inotropes and vasopressors
A hint about inotropes and vasopressors
 
Tc 99m sestamibi
Tc 99m sestamibiTc 99m sestamibi
Tc 99m sestamibi
 
Dr,nidhi gupta aiims.
Dr,nidhi gupta aiims.Dr,nidhi gupta aiims.
Dr,nidhi gupta aiims.
 

Recently uploaded

Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxDr Bilal Natiq
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 

Recently uploaded (20)

Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptxL1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
L1.INTRODUCTION to ENDOCRINOLOGY MEDICINE.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 

Myocardial Perfusion Scintigraphy Techniques

  • 1.
  • 2. Dr. Mustafa Sayed Prof . Of Nuclear Medicine Asyut University , Egypt.
  • 3.  Myocardial perfusion scintigraphy descrip sequential physiological events: -First, the materials(radiopharmacuticals) must be delivered to the myocardium. -Second, a viable metabolically active myocardial cell must be present to extract this material. -Finally, a significant amount of the material must remain within the cell to allow for imaging.  The scintigraphic images are a map of regional myocardial perfusion.  If a patient has reduced regional perfusion as a result of hemodynamically significant (CAD) or a loss of cell viability as a result of myocardial infarction, a perfusion defect or cold region is seen on the images.  All diagnostic patterns in the many diverse applications follow from these observations
  • 4.  The radiopharmaceutical is a combination of radioactive material used alone or mixed with inert kits. These materials have selective affinity to target cell components.  These radiopharmaceuticals emit gamma rays which are collected by special instrumentations called gamma camera which has different types.  These types include multi view planar imaging which was followed by single-photon emission tomography (SPECT), gated SPECT, SPECT/CT, then positron emission tomography (PET),and PET/CT.
  • 5.  Such radipharmaceuticals are injected under stress as well as resting conditions, and images are obtained to define the regional distribution of radioactivity within the myocardium.   First used for myocardial scintigraphy in the mid- 1970s, it was the only perfusion agent available until the 1990s, when Tc-99m–labeled radiotracers were introduced. Tl-201 is less commonly used today because of its poorer image quality.  At some imaging clinics it is used for the rest study in dual-isotope studies or for viability studies
  • 6.  Mechanism of Localization and Pharmacokinetics: After intravenous injection, Tl-201 blood clearance is rapid. It is transported across the myocardial cell membrane via the Na+/K+ ATPase pump. More than 85% is extracted by the myocardial cell on first pass through the coronary capillary circulation . Peak myocardial uptake occurs by 10 minutes. Approximately 3% of the administered dose localizes in the myocardium. Extraction is proportional to relative regional perfusion over a range of flow rates. At high flow rates, extraction efficiency decreases; at low rates, it increases. It can only be extracted by viable myocardium, but not in regions of infarction or scar.
  • 7. Tc-99m is the radiotracer which emits gamma rays and can be labelled with different materials. = Technetium-99m MIBI: approved by the (FDA) for clinical use in 1990. Generic Tc-99m sestamibi became available late (chemical name: hexakis 2- ೦Methoxy Iso Butyl Isonitrile). Mechanism of Localization and Uptake: Because it is lipid soluble, Tc-99m mibi diffuses from the blood into the myocardial cell. It is retained intracellular in the mitochondria because of its negative transmembrane potential. First-pass extraction fraction is 60% . Extraction is proportional to coronary blood flow.
  • 8. = Technetium-99m Tetrofosmin:Tc-99m tetrofosmin (Myoview) was approved by the FDA in 1996. An advantage over Tc-99m mibi is its more rapid liver clearance.  Mechanism of Localization and Uptake: Similar to mibi, Tc-99m tetrofosmin is a lipophilic cation that localizes inside mitochondria in the myocardial cell and remains fixed at that site. First-pass extraction is slightly less than that of mibi (50% vs. 60%). Extraction is proportional to blood flow, but underestimated at high flow rates. It is widely used nowadays.
  • 9.  Single Photon Emission Computed Tomography: SPECT is the standard method for myocardial perfusion scintigraphy. The cross-sectional images have high contrast resolution and are displayed three-dimension along the short and long axis of the heart providing good delineation of the various regional myocardial perfusion beds supplied by their individual coronary arteries.
  • 10. The diagram shows a photon reaching the NaI crystal through the collimator and undergoing photoelectric absorption. The photomultiplier tubes (PMTs) are optically coupled to the NaI crystal. The electrical outputs from the respective PMTs are further processed through positioning circuitry to calculate (x, y) coordinates and through addition circuitry to calculate the deposited energy of the pulse. The energy signal passes through the pulse height analyzer. If the event is accepted, it is recorded spatially in the location determined by the (x,y) positioning pulses to form the image.
  • 11.
  • 12. Cardiac SPECT software: reconstructs cross-sectional cardiac images along the short and long axes of the heart , that is, transaxial (short axis), coronal (horizontal long axis), and sagittal (vertical long axis) . The SPECT cross-sectional images descrip the regional perfusion of the myocardium as it relates to the coronary artery supplying blood to that region and permits visual estimation of the degree and extent of the perfusion abnormality
  • 13.
  • 14.  Cardiac stress testing with ECG monitoring has long been used to diagnose ischemic coronary artery diseases.  Cardiac stress can be physical by graded treadmill or pharmacological with specific drugs.  The SPECT imaging provides valuable information on the extent and severity of coronary artery disease which is useful for risk assessment, prognosis, and patient management.
  • 15.  The patients must be fasting for 4 to 6 hours before the test to prevent stress-induced gastric distress and minimize splanchnic blood distribution.  Cardiac medications may be held depending on the indication for the stress test—that is, whether for diagnosis or to determine the effectiveness of therapy and type of stress. Beta blockers may prevent achievement of maximum heart rate. Nitrates and calcium channel blockers may mask or prevent cardiac ischemia,so limiting the test’s diagnostic value. Assessment of drug therapy effectiveness requires the patient to remain on medication. Thyophylline and caffeine also held before pharmacological test.
  • 16. Withdrawal Drugs interval 48 hours 24 hours (also with pharma.) 24 hours (also with pharma.) 24 hours 24 hours In EXERCIS beta blockers Calcium channel blockers Nitrates In PHARMACOLOGICAL Thyophylline derivatives Caffeine
  • 17.  In addition to a standard 12-lead baseline ECG, an intravenous line is kept open. The patient is continuously monitored during the study.  Graded treadmill exercise is performed according to a standardized Bruce protocol.  When the patient has achieved maximal exercise or peak patient tolerance the radio-pharmaceutical is injected.  The adequacy of exercise is judged by the degree of cardiac work. Patients achieving more than 85% of the age-predicted maximum heart rate (220 − age = maximum predicted heart rate) are considered to have achieved adequate exercise, stress metabolic equivalents (METS) also can be used to judge the adequacy of exercise. Failure to achieve adequate exercise is the most common reason for a false negative stress test result.  Exercise is continued for another 1 minute after injection of radiotracer to ensure adequate uptake.  Early discontinuation of exercise may result in tracer distribution reflecting perfusion at sub maximal exercise levels.
  • 18. 1- Coronary Vasodilating Drugs: Dipyridamole, Adenosine, and Regadenoson.  Dipyridamole (Persantine) and adenosine (Adenoscan) are coronary vasodilating drugs that have long been used for stress myocardial perfusion imaging. Regadenoson (Lexiscan) was approved by the FDA in 2009 but dipyridamole is the widely used .  The vasodilators increase coronary blood flow in normal vessels 3 to 5 times. Because coronary arteries with significant stenoses cannot increase blood flow to the same degree as normal vessels, vasodilator stress results in vascular regions of relative hypoperfusion on myocardial perfusion scintigraphy similar to that seen with exercise-induced ischemia.
  • 19.  Dipyridamole injection protocol: - Dose 0.56 mg / Kg diluted in 50 ml normal saline and given as infusion for 4 minutes. - The radiopharmaceutical should be injected after 2-4 minutes after completion of infusion. - It is contraindicated in bronchial asthma and preferred in LBBB cases. - Heart rate, blood pressure and ECG should be measured and recorded at baseline and every 2 minutes during the infusion until stress-induced haemodynamic changes are improving and the patient regains baseline status.
  • 20.  2- Inotropic Drugs: Dobutamine is a synthetic catecholamine that acts on alpha- and beta-adrenergic receptors producing inotropic and chronotropic effects that increase cardiac work.  In normal coronary arteries, increased blood flow is the result. In the face of significant stenosis, regional flow does not increase, producing scintigraphic patterns similar to that seen with ischemia .  Dobutamine injection protocol: Initial infusion rate is 5 μg/kg/min over 3 minutes, then increased to 10 μg/kg/min for another 3 minutes and further increased by that amount every 10 minutes until a maximum of 40 μg/kg/min is achieved. The radiopharmaceutical is injected after the maximal tolerable dose reaching the target heart rate and the dobutamine infusion is continue for 1 minute.
  • 21. Stress Rest Radiopharmaceutical 25 m Ci 25 m Ci dose Supine or prone 45-60 min. Supine or prone 20 – 30 min with exercise 45-60 min with drugs Patient position Injection - Imaging Time
  • 22.
  • 23.
  • 24.
  • 25.
  • 26. After initial assessment of the presence or absence of perfusion defects, a complete evaluation of the stress study includes assessment of the location, size, severity, and likely vascular distribution of the visualized abnormalities. A true perfusion defect should be seen on more than one cross-sectional slice and in other cross-section planes. Certainty increases with lesion size and the degree or severity of photon deficiency.
  • 27.
  • 28. 1 0 4 2 4 4 1 2 2 3 4 4 100% 70 50 30 10 0 4 normal 100 - 70% 3 mild 70 - 50% 2 moderate 50 - 30% 1 severe 30 - 10% 0 absent 10 - 0%
  • 29.
  • 30.
  • 31. Perfusion defects in more than one coronary artery distribution area indicate multiple vessel disease. Prognosis worsens with increasing number and size of perfusion defects . Not all significant coronary artery stenoses are always seen on stress perfusion scans. N.B. Stress-induced ischemia of the most severe stenotic lesion limits further exercise, and thus other stenoses may not be seen and multiple vessel disease may be underestimated.
  • 32.
  • 33. The normal cardiac response is to dilate mildly during stress and return to normal size promptly with cessation of exercise. Post stress significant ventricular dilation is abnormal and suggests multi vessel disease. One explanation for this finding is myocardial stunning during stress ,another is widespread subendocardial ischemia.
  • 34.
  • 35. The effects of soft tissue attenuation can be seen on most cardiac images and are worse with large patients. Males typically have decreased activity in the inferior wall . This is called diaphragmatic attenuation, meaning attenuation by subdiaphragmatic organs interpositioned between the heart and gamma camera. The amount of attenuation effect is dependent on patient size, shape, and internal anatomy.
  • 36.
  • 37. Women often have relatively decreased activity in the anterior wall, apex, or anterior lateral portion of the heart, secondary to breast attenuation, depending on the size and position of the breasts. Women also may have sub diaphragmatic attenuation, but breast attenuation is dominant and most commonly noted. The cinematic rotating raw data should be reviewed for the presence of attenuation and motion. If the breasts are in different positions for the two studies, this could be misinterpreted as ischemia
  • 38.
  • 39.
  • 40. Exercise-induced reversible hypo perfusion of the septum can be seen in patients with left bundle branch block (LBBB) in the absence of coronary disease. Typically, the apex and anterior wall are not involved, as would be expected with left anterior descending (LAD) coronary artery disease. The stress-induced decreased septal blood flow is thought to be caused by asynchronous relaxation of the septum, which is out of phase with diastolic filling of the remainder of the ventricle when coronary perfusion is maximal. This scan abnormality is less seen with pharmacological stress, and thus the latter is indicated in patients with LBBB or ventricular pacemakers.
  • 41.
  • 42.  ECG is acquired at the time of the SPECT acquisition for simultaneous assessment of perfusion and function of the left ventricle in one examination.  Evaluation of regional wall motion and systolic thickening of the left ventricular walls .  Left ventricular end-diastolic volume, end-systolic volume, stroke volume and ejection fraction may be calculated automatically, although the values obtained should be checked against initial qualitative assessment
  • 43.
  • 44.
  • 45.
  • 46.  Decreased sensitivity and specificity in single vessel CAD ( 60 – 76% )  Diffuse disease in all three vessels (Balanced ischemia)  Diffuse disease without segmental stenosis (Vulnerable for plaque rupture and coronary events)  Early disease identification  Artifacts – Non uniform attenuation  Relative low efficiency of Gamma camera  Longer acquisition protocols